Aytu BioPharma, Inc.
Aytu BioPharma, Inc. (AYTU) — Form DEF 14A: Proxy statement
About this filing
Aytu BioPharma, Inc. (AYTU) filed Form DEF 14A (proxy statement) with the SEC on Oct 22, 2026.
Key facts
- Document
- FORM DEF 14A
More AYTU filings
- SC 14D9
Filed Nov 20, 2026
- SC TO-C
Filed Nov 16, 2026
- 10-Q
Filed Nov 16, 2026
- 8-K
Filed Nov 16, 2026
- 425
Filed Nov 16, 2026
- 8-K
Filed Nov 16, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.